CXCL14 and urinary bladder carcinoma: Furthermore, CXCL14 was found to be highly expressed in subtype 1 and studies suggested that this chemokine is responsible for better prognosis in prostate cancer which opens up a possibility for this chemokine to become an effective marker for bladder cancer.